| 1 |
34236783 | Rapamycin and Paclitaxel Affect Human Aortic Smooth Muscle Cells-Derived Foam Cells Viability and Proliferation. | 2022 May 2 |
1 |
| 2 |
35163066 | Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model. | 2022 Jan 20 |
2 |
| 3 |
33556340 | TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer. | 2021 Apr |
6 |
| 4 |
34293716 | The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance. | 2021 Aug |
1 |
| 5 |
31545524 | A pilot study to assess oxidative and inflammatory markers as early indicator for response to chemotherapy in non-small cell lung cancer. | 2020 Feb |
1 |
| 6 |
31919136 | Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218. | 2020 Mar 15 |
1 |
| 7 |
31969555 | Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice. | 2020 Jan 22 |
2 |
| 8 |
32485058 | Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy. | 2020 Jul |
2 |
| 9 |
32634713 | Bone interface modulates drug resistance in breast cancer bone metastasis. | 2020 Nov |
1 |
| 10 |
32998017 | Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1/miR-370-3p/HMGB1 axis. | 2020 Dec 1 |
1 |
| 11 |
30863067 | Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes. | 2019 |
2 |
| 12 |
31772161 | Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer. | 2019 Nov 26 |
2 |
| 13 |
31797089 | Anti-HIV, antitumor and immunomodulatory activities of paclitaxel from fermentation broth using molecular imprinting technique. | 2019 Dec 3 |
1 |
| 14 |
29486738 | Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. | 2018 Feb 27 |
3 |
| 15 |
29565447 | CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway. | 2018 May |
2 |
| 16 |
29902349 | Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro. | 2018 Aug |
1 |
| 17 |
30355931 | Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis. | 2018 |
1 |
| 18 |
29093604 | Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells. | 2017 Oct |
2 |
| 19 |
31271140 | Efficient Suppression of Liver Metastasis Cancers by Paclitaxel Loaded Nanoparticles in PDLLA-PEG-PDLLA Thermosensitive Hydrogel Composites. | 2017 Nov 1 |
1 |
| 20 |
25544427 | Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. | 2015 Mar |
5 |
| 21 |
25760537 | Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4. | 2015 Feb |
1 |
| 22 |
24527095 | TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro. | 2014 Mar |
2 |
| 23 |
22923236 | Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. | 2012 Oct |
1 |
| 24 |
20236757 | Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. | 2010 Sep 1 |
8 |
| 25 |
21122157 | Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. | 2010 Dec 2 |
1 |
| 26 |
18587580 | CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. | 2009 Mar |
1 |
| 27 |
19046877 | Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells. | 2009 Feb |
1 |
| 28 |
19619321 | KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells. | 2009 Jul 20 |
2 |
| 29 |
19826413 | TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. | 2009 Dec 10 |
1 |
| 30 |
16005497 | Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. | 2006 |
1 |
| 31 |
16547493 | Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. | 2006 Aug 10 |
8 |
| 32 |
16773437 | Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. | 2006 Dec |
2 |
| 33 |
14698135 | Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. | 2004 Feb 7 |
1 |
| 34 |
12581572 | A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. | 2003 Feb |
1 |
| 35 |
14581275 | Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. | 2003 Nov |
2 |
| 36 |
12027404 | Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells. | 2002 Mar 7 |
8 |
| 37 |
12085250 | Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. | 2002 Jul 1 |
1 |
| 38 |
11240649 | Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. | 2000 Jan |
3 |
| 39 |
10405348 | Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol. | 1999 Jul 22 |
1 |
| 40 |
10589757 | Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. | 1999 Nov |
2 |
| 41 |
9563900 | Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells. | 1998 Apr |
6 |
| 42 |
8651611 | Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. | 1996 Apr 30 |
1 |